Verisk Analytics (VRSK)
(Delayed Data from NSDQ)
$263.48 USD
-0.52 (-0.20%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $263.42 -0.06 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$263.48 USD
-0.52 (-0.20%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $263.42 -0.06 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Zacks News
Verisk (VRSK) Up 4.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Verisk (VRSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Verisk's G2 Teams up With NABP for Merchant Certification
by Zacks Equity Research
Verisk's (VRSK) G2 and NABP aims at easing the search of safe online pharmacies for customers.
Why You Should Retain Verisk Analytics (VRSK) Stock for Now
by Zacks Equity Research
Verisk continues to witness higher organic revenue growth through increase in customers, cross-sale of existing solutions and the sale of new solutions.
Verisk's Geomni Unveils Aerial Imagery Subscription Service
by Zacks Equity Research
The recent launch is expected to help Verisk (VRSK) enhance its Insurance Segment.
Verisk (VRSK) Rides on Organic Growth & Buyouts, Debt High
by Zacks Equity Research
Verisk (VRSK) continues to acquire and invest in companies globally to expand its data and analytics capabilities across industries.
The Zacks Analyst Blog Highlights: Nike, 3M, Vertex, PepsiCo and Verisk
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, 3M, Vertex, PepsiCo and Verisk
Top Stock Reports for Nike, 3M & Vertex
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Nike (NKE), 3M (MMM) and Vertex (VRTX).
Verisk Analytics (VRSK) Misses on Q4 Earnings, Beats Revenues
by Shuvra Shankar Dey
Verisk Analytics (VRSK) reports earnings decline in Q4. However, revenues increase year over year.
Verisk (VRSK) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Organic growth, lower tax rate and contributions from acquisitions are likely to boost Verisk's (VRSK) Q4 results.
Verisk Analytics (VRSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Verisk (VRSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Verisk Unveils Black Box 3 for Smart Underwriting Decisions
by Zacks Equity Research
The launch of Black Box 3 is expected to help Verisk (VRSK) enhance its Insurance Segment and strengthen global presence.
Verisk's Xactware Introduces Repair Estimation Application
by Zacks Equity Research
The new offering is likely to boost Verisk's (VRSK) insurance segment that provides repair cost estimating solutions.
Why a Hold Strategy is Apt for Verisk Analytics (VRSK) Stock
by Zacks Equity Research
Verisk continues to witness higher organic revenue growth through increase in customers, cross-sale of existing solutions and the sale of new solutions.
Verisk (VRSK) Stock Rises 12% Year to Date: Here's Why
by Zacks Equity Research
Verisk (VRSK) continues to benefit from acquisitions and organic growth. The company's predictive data analytics portfolio is another growth factor.
Verisk Analytics (VRSK) Signs Agreement for Rulebook Buyout
by Zacks Equity Research
The Rulebook acquisition is likely to boost Verisk's (VRSK) Insurance segment.
Why Is Verisk (VRSK) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Verisk (VRSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Verisk Stock in Your Portfolio
by Zacks Equity Research
Verisk's (VRSK) business strategy includes growth through technological prowess and acquisitions.
Verisk Rides on Data Analysis Expertise, Debt Woes Remain
by Zacks Equity Research
Verisk's (VRSK) predictive data analytics portfolio looks good. While it continues to grow with the help of acquisitions and organic growth, high debt remains a major concern.
Verisk Analytics (VRSK) Beats on Q3 Earnings, Lags Revenues
by Zacks Equity Research
Verisk Analytics' (VRSK) Q3 results benefit from strong organic revenue growth as well as 2017 tax reform policy.
Verisk Analytics (VRSK) Tops Q3 Earnings Estimates
by Zacks Equity Research
Verisk (VRSK) delivered earnings and revenue surprises of 0.93% and -0.20%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Verisk (VRSK) Q3 Earnings: Is Disappointment in the Cards?
by Zacks Equity Research
Organic growth, lower tax rates and contributions from acquisitions are likely to boost Verisk's (VRSK) third-quarter 2018 results.
Verisk Analytics (VRSK) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Verisk (VRSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How IQVIA Will Benefit From Genomics England Allaince
by Zacks Equity Research
IQVIA's (IQV) partnership with Genomics England is expected to boost the Technology & Analytics Solutions segment.
Here's Why Verisk (VRSK) Stock is Up 23.3% Year to Date
by Zacks Equity Research
Verisk (VRSK) continues to benefit from acquisitions and organic growth.
Verisk's Geomni and DroneBase Ink Strategic Partnership
by Zacks Equity Research
The partnership is likely to benefit Verisk's (VRSK) Insurance segment.